Our health, and consequently our lives, depend on the coordinated activities of our individual cells; diseases arise when the activities of these individual cells become derailed.
Through our combined expertise in different cell types and communication mechanisms and using state-of-the-art approaches, scientists in VAI’s Department of Cell Biology pursue fundamental research to understand how our cells grow, communicate, survive, assemble into tissues and organs, respond to the environment, and change with age.
This transformative work will yield new diagnostic and treatment strategies to improve the quality of life for people with cancer, bone diseases and rare disorders.
Tao Yang, Ph.D.
Interim Chair and Associate Professor, Department of Cell Biology
Stephanie Grainger, Ph.D.
Assistant Professor, Department of Cell Biology
Wnt Signaling in Hematopoietic Stem Cell Development and Cancer
Brian Haab, Ph.D.
Professor, Department of Cell Biology; Assistant Dean, Van Andel Institute Graduate School
Scott Jewell, Ph.D.
Director, Pathology and Biorepository Core
Professor, Department of Cell Biology
Matt Steensma, M.D.
Associate Professor, Department of Cell Biology
Bart Williams, Ph.D.
Director, Core Technologies and Services; Professor, Department of Cell Biology
Cell Signaling and Carcinogenesis
Sonya Craig, Ph.D.
Scientific Grant Writer, Department of Cell Biology
Administrative Assistant II, Department of Cell Biology
Latest from VaiLearn More
Did you miss our 2022 Public Lecture Series? We have you covered.
Van Andel Institute Graduate School student awarded PhRMA Foundation Predoctoral Fellowship to pursue new osteoarthritis therapies
Graduate student spotlight: Exploring biomarkers to improve pancreatic cancer detection and diagnosis
We're raising thousands to save millions
We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.
- 118 papers published in 2022
- 48 papers in high-impact journals in 2022
- 42 clinical trials launched